Towards the Optimal Screening Collection: A Synthesis Strategy

The development of effective small-molecule probes and drugs entails at least three stages: 1) a discovery phase, often requiring the synthesis and screening of candidate compounds, 2) an optimization phase, requiring the synthesis and analysis of structural variants, 3) and a manufacturing phase, r...

Full description

Saved in:
Bibliographic Details
Published inAngewandte Chemie International Edition Vol. 47; no. 1; pp. 48 - 56
Main Authors Nielsen, Thomas E, Schreiber, Stuart L
Format Journal Article
LanguageEnglish
Published Weinheim Wiley-VCH Verlag 2008
WILEY-VCH Verlag
WILEY‐VCH Verlag
Subjects
Online AccessGet full text
ISSN1433-7851
1521-3773
1521-3773
DOI10.1002/anie.200703073

Cover

More Information
Summary:The development of effective small-molecule probes and drugs entails at least three stages: 1) a discovery phase, often requiring the synthesis and screening of candidate compounds, 2) an optimization phase, requiring the synthesis and analysis of structural variants, 3) and a manufacturing phase, requiring the efficient, large-scale synthesis of the optimized probe or drug. Specialized project groups tend to undertake the individual activities without prior coordination; for example, contracted (outsourced) chemists may perform the first activity while in-house medicinal and process chemists perform the second and third development stages, respectively. The coordinated planning of these activities in advance of the first small-molecule screen tends not to be undertaken, and each project group can encounter a bottleneck that could, in principle, have been avoided with advance planning. Therefore, a challenge for synthetic chemistry is to develop a new kind of chemistry that yields a screening collection comprising small molecules that increase the probability of success in all three phases. Although this transformative chemistry remains elusive, progress is being made. Herein, we review a newly emerging strategy in diversity-oriented small-molecule synthesis that may have the potential to achieve these challenging goals.
Bibliography:http://dx.doi.org/10.1002/anie.200703073
ark:/67375/WNG-KQ3LP1MC-6
ArticleID:ANIE200703073
istex:9BDB6CA55B47616AEF44C83898CC301B88111D1B
The NIGMS-sponsored Center of Excellence in Chemical Methodology and Library Development (Broad Institute CMLD) enabled this research. T.E.N. is grateful to the Alfred Benzon Foundation for a postdoctoral research scholarship. S.L.S. is an investigator with the Howard Hughes Medical Institute.
The NIGMS‐sponsored Center of Excellence in Chemical Methodology and Library Development (Broad Institute CMLD) enabled this research. T.E.N. is grateful to the Alfred Benzon Foundation for a postdoctoral research scholarship. S.L.S. is an investigator with the Howard Hughes Medical Institute.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Review-3
ISSN:1433-7851
1521-3773
1521-3773
DOI:10.1002/anie.200703073